Another oncology tidbit today, as Texas Oncology announced it’s been awarded a 2018 Pharmacy Benefit Management Institute Excellence Award.
The recognition has to do with Texas Oncology’s care management strategies, and with its success in raising adherence to oncology meds to 96 percent, whereas the national average sits around 70 percent. Oral chemotherapy, Texas Oncology says, is taking on a greater importance in cancer care with more and more drugs being introduced to the market.
“A medically integrated care approach with physicians, nurses, pharmacists, nutritionists, and financial counselors working together improves patient experiences and compliance while reducing costs from less waste, fewer side effects, and fewer hospitalizations,” said Jim Schwartz, executive director of pharmacy operations at Texas Oncology Pharmacy, in a statement. “We are grateful for this award and for our amazing team members who provide active, patient-centered care throughout the treatment process.”
